ICARES Medicus, Inc. (TPEX:6612)

Market Cap	3.25B -41.7%
Revenue (ttm)	1.09B +46.5%
Net Income	63.38M -4.1%
EPS	1.34 -5.0%
Shares Out	47.38M
PE Ratio	51.11
Forward PE	n/a
Dividend	0.27 (0.39%)
Ex-Dividend Date	Aug 22, 2025

Volume	24,452
Average Volume	60,853
Open	69.30
Previous Close	69.30
Day's Range	68.60 - 69.50
52-Week Range	66.30 - 123.64
Beta	0.37
RSI	37.34
Earnings Date	Mar 12, 2026

About ICARES Medicus

ICARES Medicus, Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of ophthalmic medical devices in Taiwan, the United States, England, Japan, Spain, China, and internationally. The company is also involved in the manufacturing, sales, and service of intraocular lenses (IOLs) and its implantation systems for use in treating cataracts, myopia, hyperopia, presbyopia, or astigmatism. In addition, it offers lubricious coatings and various surface treatments for implantable or interventional medical d...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2011
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6612

Financial Performance

In 2024, ICARES Medicus's revenue was 859.79 million, an increase of 42.01% compared to the previous year's 605.45 million. Earnings were 103.12 million, an increase of 5.52%.